These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23066177)

  • 21. Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.
    Reed GW; Abdallah MS; Shao M; Wolski K; Wisniewski L; Yeomans N; Lüscher TF; Borer JS; Graham DY; Husni ME; Solomon DH; Libby P; Menon V; Lincoff AM; Nissen SE
    J Am Coll Cardiol; 2018 Apr; 71(16):1741-1751. PubMed ID: 29673465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved percutaneous delivery of some NSAIDs for the treatment of arthritis.
    Thosani R; Pawar V; Giridhar R; Yadav MR
    J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S12-3. PubMed ID: 23066187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs.
    Mallen SR; Essex MN; Zhang R
    Curr Med Res Opin; 2011 Jul; 27(7):1359-66. PubMed ID: 21561397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.
    Litalien C; Jacqz-Aigrain E
    Paediatr Drugs; 2001; 3(11):817-58. PubMed ID: 11735667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs).
    Rainsford KD
    Am J Med; 1999 Dec; 107(6A):27S-35S; discussion 35S-36S. PubMed ID: 10628591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Study of Analgesic and Anti-inflammatory Activities of Amide Derivatives of Ibuprofen.
    Ahmadi A; Khalili M; Olama Z; Karami S; Nahri-Niknafs B
    Mini Rev Med Chem; 2017; 17(9):799-804. PubMed ID: 28029080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiorenal Safety of OTC Analgesics.
    White WB; Kloner RA; Angiolillo DJ; Davidson MH
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):103-118. PubMed ID: 29421936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review.
    Parolini M
    Sci Total Environ; 2020 Oct; 740():140043. PubMed ID: 32559537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.
    Prescrire Int; 2016 Jan; 25(167):14-6. PubMed ID: 26942254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity.
    Kotilinek LA; Westerman MA; Wang Q; Panizzon K; Lim GP; Simonyi A; Lesne S; Falinska A; Younkin LH; Younkin SG; Rowan M; Cleary J; Wallis RA; Sun GY; Cole G; Frautschy S; Anwyl R; Ashe KH
    Brain; 2008 Mar; 131(Pt 3):651-64. PubMed ID: 18292081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronological effects of non-steroidal anti-inflammatory drug therapy on oxidative stress and antioxidant status in patients with rheumatoid arthritis.
    Nawaz H; Ali A; Rehman T; Aslam A
    Clin Rheumatol; 2021 May; 40(5):1767-1778. PubMed ID: 33009599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.
    Mastbergen SC; Jansen NW; Bijlsma JW; Lafeber FP
    Arthritis Res Ther; 2006; 8(1):R2. PubMed ID: 16356188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.
    Yeomans ND; Graham DY; Husni ME; Solomon DH; Stevens T; Vargo J; Wang Q; Wisniewski LM; Wolski KE; Borer JS; Libby P; Lincoff AM; Lüscher TF; Bao W; Walker C; Nissen SE;
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1453-1463. PubMed ID: 29667211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of rofecoxib, a cyclooxygenase-2-specific inhibitor, for the treatment of non-cancer pain: a review.
    Fine PG;
    J Pain; 2002 Aug; 3(4):272-83. PubMed ID: 14622751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model.
    Katri A; Dąbrowska A; Löfvall H; Ding M; Karsdal MA; Andreassen KV; Thudium CS; Henriksen K
    Arthritis Res Ther; 2019 Feb; 21(1):68. PubMed ID: 30795801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.